Earnings Neutral

Birchtech Reports Fourth Quarter 2025 Financial Results

Birchtech Secures Capital and Court Win, But Profitability and Appeal Risks Cap Upside

By The Northwire Desk — AI Analysis Mar 31, 2026 · 16:05 BCHT · 2.48 BIRCHTECH CORP

Executive Summary

Birchtech reported Q4 2025 product revenues of $3.6M, up 19.8% year-over-year, with total revenue at $3.8M.
Gross profit declined to $1.2M (31% margin) from $3.3M in the prior year quarter, primarily due to a one-time licensing fee recognized in the prior period.
SG&A expenses fell 42% YoY to $2.0M, while R&D expenses were $0.5M. Net loss narrowed to $0.6M ($0.03/share) from a $1.3M loss YoY. Adjusted EBITDA widened to $(1.1)M from $(0.5)M.
Cash balance stood at $2.2M at year-end 2025, with zero debt.
The company closed a concurrent public offering raising approximately $16.6M in gross proceeds at $2.40 per share, alongside its February 2026 uplisting to NYSE American.
A final federal court judgment of ~$78M was secured in a patent infringement case against refined-coal operators. Defendants have appealed, and collection efforts have begun.
Operational updates include the launch of the SEA-IX nuclear-grade ion exchange resin line, ~$0.9M in purchase orders from a mid-Atlantic utility, successful thermally rejuvenated GAC demonstrations, and a testing collaboration with Civil & Environmental Consultants (CEC).

Material Impact

The Q4 financials show top-line growth but a regression in profitability compared to Q3 2025, which reported net income of $0.8M. Gross margin compression highlights reliance on non-recurring licensing fees rather than sustainable product margins.
The $16.6M capital raise provides necessary liquidity but dilutes existing shareholders. The stock trading near the $2.40 offering price indicates the market has fully priced in the dilution and views the raise as a baseline requirement rather than a growth catalyst.
The $78M litigation win is material on paper but heavily discounted due to the pending appeal and uncertain collection timeline. It cannot be recognized as revenue until realized.
The SEA-IX resin launch and $0.9M POs validate the water-treatment pivot but remain incremental. They do not yet offset the core business's profitability challenges.
Overall, the release confirms previously announced milestones without delivering unexpected upside. The mixed financials and appeal risk keep the impact routine and neutral.

BCHT · Price

Company Overview

Birchtech operates in the environmental technology sector, focusing on air and water purification solutions for industrial and municipal clients.
Flagship Project: The SEA® mercury emissions capture technology for coal-fired utilities, which has generated ~$37M in cumulative licensing revenue since 2020.
Strategic Pivot: Expanding into a comprehensive water-treatment platform, including granular activated carbon (GAC) media, thermally rejuvenated GAC, and the newly launched SEA-IX nuclear-grade ion exchange resins.
The company is transitioning from a litigation/licensing-driven model to a commercial product and service provider, targeting PFAS compliance and wastewater treatment markets.

More from BIRCHTECH CORP